CHRISTIAN ENGLE: Open Payments
NPI 1881300911 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 25 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $175 |
| Novo Nordisk Inc | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Amgen Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $14 |
Products named: Wegovy, QULIPTA, UBRELVY, TRULANCE, DALVANCE, VRAYLAR, OTEZLA, REXULTI.
Industry payments across AL — which companies pay providers there.
